Trinity Biotech

TRIB | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.34

-$0.01 (-0.14%)

Sep 22, 2026, 12:01 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-37.38M	-31.79M	-24.02M	-41.01M	875K	-6.39M
Depreciation & Amortization	2.68M	1.87M	1.78M	2.33M	2.74M	3.08M
Stock-Based Compensation	324K	1.32M	2.07M	1.76M	1.1M	792K
Other Working Capital	2.02M	10.3M	-478K	7.57M	5.59M	5.06M
Other Non-Cash Items	21.21M	17.74M	11.37M	37.85M	8.86M	22.31M
Deferred Income Tax	199K	486K	-59K	-192K	-167K	-182K
Change in Working Capital	7.03M	6.19M	-2.69M	-1.66M	-172K	4.15M
Operating Cash Flow	-5.93M	-4.19M	-11.56M	-921K	13.24M	23.76M
Capital Expenditures	-6.22M	-10.06M	-803K	-5.98M	-8.69M	-10.2M
Cash Acquisitions	n/a	-12.9M	28.16M	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	-700K	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-6.14M	-9.66M	-1.9M	-4.88M	-6.88M	n/a
Investing Cash Flow	-6.22M	-22.97M	24.76M	-5.98M	-8.69M	-10.2M
Debt Repayment	11.81M	27.67M	-7.37M	-27.04M	-2.94M	-3.24M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-308K	-6.25M	-8.67M	-10.61M	-3.08M	524K
Financial Cash Flow	12.05M	28.81M	-16.04M	-12.32M	-6.02M	-2.72M
Net Cash Flow	-29K	1.48M	-2.89M	-19.33M	-1.42M	10.93M
Free Cash Flow	-12.15M	-14.26M	-12.36M	-6.9M	4.55M	13.56M
Adj. Free Cash Flow	-12.48M	-15.57M	-14.43M	-8.65M	3.45M	12.77M
Maintenance CapEx	-6.22M	-9.71M	-803K	-5.98M	-8.69M	-8.85M
Growth CapEx	n/a	-353.8K	n/a	n/a	n/a	-1.35M
Owner Earnings	-12.15M	-13.9M	-12.36M	-6.9M	4.55M	14.9M